Abbott’s Medical Camps In India: Genuine Effort or Proxy Sales Plan?

US multinational Abbott is under fire in India for allegedly using medical “camps” and a questionable “survey” approach to bolster prescriptions for its diabetic neuropathy drug, Surbex Star. Abbott has strongly denied any wrong-doing but some experts suggest it’s probably tough to delink the rub-off such activities could have on brand building.

Are Abbott’s medical camps in India just that or are they a surrogate sales booster strategy? It is difficult to determine right away from afar, say some industry watchers. Abbott India has underscored that its intentions are clean and that it has “no role in recommendation or execution of treatments” to patients - that is solely at the discretion of the physician.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from India

More from Focus On Asia